Last reviewed · How we verify

NCT06871566

AI-Supported Occupational Therapy for Handwriting

Completed NA Last updated 12 March 2025
What this trial tests

NA trial testing Artificial Intelligence-Supported Occupational Therapy Program in Occupational Therapy in 42 participants. Completed in 30 August 2024.

Timeline
12 April 2024
Primary endpoint
20 August 2024
30 August 2024

Quick facts

Lead sponsorHacettepe University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment42
Start date12 April 2024
Primary completion20 August 2024
Estimated completion30 August 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

Adults 8 to 12, any sex, with Occupational Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim: This study investigates the impact of an AI-supported occupational therapy program, developed using the Model of Human Occupation (MOHO), on handwriting skills in children at risk for Developmental Coordination Disorder (DCD). Method: A randomized controlled trial was conducted with 42 children aged 8-12 years, identified as being at risk for DCD using the Developmental Coordination Disorder Questionnaire (DCDQ). Participants were randomized into an intervention group (n=21) and a control group (n=21). The intervention group received an AI-supported occupational therapy program twice weekly for 8 weeks. Handwriting performance was assessed pre- and post-intervention using the Minnesota Handwriting Assessment (MHA). Keywords: artificial intelligence, occupational

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Occupational Therapy

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06871566.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing